secwatch.observer — SEC 8-K summary
======================================

Issuer:     TuHURA Biosciences, Inc./NV (HURA)
CIK:        0001498382
Form:       8-K
Filed at:   2021-11-12T23:59:59+00:00
Accession:  0001564590-21-056375
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kintara names Robert Hoffman as CEO; Saiid Zarrabian transitions to Head of Strategic Partnerships
--------------------------------------------------------------------------------

- Robert E. Hoffman appointed President and CEO effective Nov 8, 2021; previously Chairman.
- Saiid Zarrabian steps down as CEO, becomes Head of Strategic Partnerships.
- Hoffman receives $551k base salary, 3,519,170 stock option grant (4-yr vest), target bonus up to 50%.
- Zarrabian's new salary $285k, target bonus up to 40%; unvested options now tied to milestones.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1498382/000156459021056375/0001564590-21-056375-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1498382/000156459021056375/ktra-8k_20211108.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-056375

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer